Before you consider Eli Lilly and Company, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Eli Lilly and Company wasn’t on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
Which stocks are hedge funds and endowments buying in today’s market? Enter your email address and we’ll send you MarketBeat’s list of thirteen stocks that institutional investors are buying now.
